Insider Trading History of Seizinger Bernd R.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Seizinger Bernd R. since 2019. This trader's CIK number is 1789042. At the time of last reporting, Seizinger Bernd R. was the Officer of Aprea Therapeutics, Inc.. (stock ticker symbol APRE). Also see all insider trading activities at Aprea Therapeutics, Inc..

Note that in the past Seizinger Bernd R. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aptose Biosciences Inc. (APTO) by Seizinger Bernd R.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 APTO 17,000 $53,380 0 $0 0 $0

Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Seizinger Bernd R.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 APRE 16,860 $76,809 0 $0 0 $0
2023 APRE 10,097 $36,954 0 $0 0 $0
2022 APRE 50,000 $35,500 0 $0 0 $0
2019 APRE 0 $0 0 $0 263,970 $18,477


Insider trading activities at 2 companies by Seizinger Bernd R.:

1. Aptose Biosciences Inc. (APTO)

2. Aprea Therapeutics, Inc. (APRE)

Table 1. Insider trading of Aptose Biosciences Inc. (APTO) by Seizinger Bernd R.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-22 APTO Buy 17,000 3.14 53,380

Table 2. Insider trading of Aprea Therapeutics, Inc. (APRE) by Seizinger Bernd R.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-10-11 APRE Buy 10,000 2.68 26,800
2024-03-13 APRE Buy 6,860 7.29 50,009
2023-06-07 APRE Buy 6,029 3.68 22,192
2023-06-06 APRE Buy 4,068 3.63 14,762
2022-05-18 APRE Buy 50,000 .71 35,500
2019-10-07 APRE Option Ex 263,970 .07 18,477

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Seizinger Bernd R. (Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.